Yuichiro Nakada

587 total citations
28 papers, 457 citations indexed

About

Yuichiro Nakada is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Yuichiro Nakada has authored 28 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Yuichiro Nakada's work include Nanoparticle-Based Drug Delivery (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Yuichiro Nakada is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Yuichiro Nakada collaborates with scholars based in Japan, France and United States. Yuichiro Nakada's co-authors include Elias Fattal, Patrick Couvreur, Yoshiteru Takahashi, Kazuo Sakurai, Tomomi Nakamura, Junko Matsumoto, Norio AWATA, Grégory Lambert, Christine Vauthier and ISAO SUGIMOTO and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Yuichiro Nakada

25 papers receiving 423 citations

Peers

Yuichiro Nakada
Yueqi Bi China
Lisi Qi China
M.B.F. Martins Portugal
Mohamed G. Qaddoumi Kuwait
Jiangxiu Niu China
Timothy P. Coleman United States
Vivek Patel India
Julian David Friedl Austria
Ping‐Yang Yeh United States
Ashish Jain India
Yueqi Bi China
Yuichiro Nakada
Citations per year, relative to Yuichiro Nakada Yuichiro Nakada (= 1×) peers Yueqi Bi

Countries citing papers authored by Yuichiro Nakada

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Nakada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Nakada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Nakada more than expected).

Fields of papers citing papers by Yuichiro Nakada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Nakada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Nakada. The network helps show where Yuichiro Nakada may publish in the future.

Co-authorship network of co-authors of Yuichiro Nakada

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Nakada. A scholar is included among the top collaborators of Yuichiro Nakada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Nakada. Yuichiro Nakada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohura, Kayoko, Yuichiro Nakada, & Teruko Imai. (2023). Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection. Journal of Pharmaceutical Sciences. 112(7). 1975–1984.
2.
3.
Nakada, Yuichiro, et al.. (2021). Effect of Shelf Life on the Physical Stability of Suspended Ophthalmic Solutions. YAKUGAKU ZASSHI. 141(6). 869–876. 1 indexed citations
4.
Imai, Teruko, Yuichiro Nakada, & Kayoko Ohura. (2019). Comparative Study of Hydrolase Activity in Skin with Liver and Intestine, and Its Aging Relation of Carboxylesterase Expression in Cynomolgus Monkey and Beagle Dog. YAKUGAKU ZASSHI. 139(5). 837–844. 2 indexed citations
5.
Imai, Teruko, et al.. (2015). Expression of Carboxylesterase Isozymes and Their Role in the Behavior of a Fexofenadine Prodrug in Rat Skin. Journal of Pharmaceutical Sciences. 105(2). 714–721. 5 indexed citations
6.
Ohura, Kayoko, Yuichiro Nakada, Shunsuke Kotani, & Teruko Imai. (2015). Design of Fexofenadine Prodrugs Based on Tissue-Specific Esterase Activity and Their Dissimilar Recognition by P-Glycoprotein. Journal of Pharmaceutical Sciences. 104(9). 3076–3083. 12 indexed citations
7.
Yuminoki, Kayo, et al.. (2014). Preparation and Evaluation of High Dispersion Stable Nanocrystal Formulation of Poorly Water‐Soluble Compounds by Using Povacoat. Journal of Pharmaceutical Sciences. 103(11). 3772–3781. 15 indexed citations
8.
Nakada, Yuichiro, et al.. (2004). Biopharmaceutical Considerations on Antihistamine Effects of Topically Administered Emedastine. Journal of Pharmaceutical Sciences. 94(1). 17–24. 3 indexed citations
9.
Sawa, Masaaki, Takao Kiyoi, Fumio Nakajima, et al.. (2002). New Strategy for Antedrug Application:  Development of Metalloproteinase Inhibitors as Antipsoriatic Drugs. Journal of Medicinal Chemistry. 45(4). 930–936. 37 indexed citations
10.
Nakada, Yuichiro & Yoshiteru Takahashi. (2000). Nanoparticles consisting of biodegradable ABA triblock copolymers containing of poly(L-lactic acid)A-blocks attached to central poly(oxyethylene)B-blocks.. Drug Delivery System. 15(5). 449–456. 1 indexed citations
11.
Matsumoto, Junko, Yuichiro Nakada, Kazuo Sakurai, Tomomi Nakamura, & Yoshiteru Takahashi. (1999). Preparation of nanoparticles consisted of poly(l-lactide)–poly(ethylene glycol)–poly(l-lactide) and their evaluation in vitro. International Journal of Pharmaceutics. 185(1). 93–101. 99 indexed citations
12.
13.
Nakada, Yuichiro, et al.. (1998). Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.. PubMed. 48(8). 818–21. 2 indexed citations
14.
Fattal, Elias, et al.. (1998). Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Journal of Controlled Release. 53(1-3). 137–143. 104 indexed citations
15.
Nakada, Yuichiro, et al.. (1997). Long‐circulating Nanoparticles Using Biodegradable ABA Triblock Copolymers Containing Poly(L‐lactic acid) A‐blocks Attached to Central Poly(oxyethylene) B‐blocks. Pharmacy and Pharmacology Communications. 3(10). 479–481. 4 indexed citations
16.
Nakada, Yuichiro, et al.. (1997). Metabolism of a New Antiplatelet Agent, Ethyl 2-(4, 5-bis (4-methoxyphenyl) thiazol-2-yl) pyrrol-1-ylacetate (KBT-3022), in Rats, Mice, Dogs and Humans.. Drug Metabolism and Pharmacokinetics. 12(2). 130–141. 1 indexed citations
17.
18.
Nakada, Yuichiro, et al.. (1992). VAGINAL ABSORPTION OF SODIUM PRASTERONE SULFATE AND HUMAN CALCITONIN. Journal of Pharmacobio-Dynamics. 15(2). 1 indexed citations
19.
Nakada, Yuichiro, Hitoshi Shimada, & Norio AWATA. (1992). Determination of the Main Metabolite (Desethyl KBT-3022) of a New Antiplatelet Agent, KBT-3022 in Plasma by Gas Chromatography. YAKUGAKU ZASSHI. 112(6). 414–417. 1 indexed citations
20.
Nakada, Yuichiro, et al.. (1988). The effect of additives on the oral mucosal absorption of human calcitonin in rats.. Journal of Pharmacobio-Dynamics. 11(6). 395–401. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueqi Bi Breakdown of academic impact, for papers by Lisi Qi Breakdown of academic impact, for papers by M.B.F. Martins Breakdown of academic impact, for papers by Mohamed G. Qaddoumi Breakdown of academic impact, for papers by Jiangxiu Niu Breakdown of academic impact, for papers by Timothy P. Coleman Breakdown of academic impact, for papers by Vivek Patel Breakdown of academic impact, for papers by Julian David Friedl Breakdown of academic impact, for papers by Ping‐Yang Yeh Breakdown of academic impact, for papers by Ashish Jain
Rankless by CCL
2026